Validation of the COPD severity score for use in primary care: The NEREA study

European Respiratory Journal

Volumn 33, Issue 3, 2009, Pages 519-527

  Miravitlles, M ^a,e   Llor, C ^b   De Castellar, R ^c   Izquierdo, I ^d   Baro E ^c   Donado, E ^d  

^a Hospital Clinic   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c 3D Health Research   (Spain)

^d Clinical Development and Medical Advice   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Outcome assessment; Primary care; Questionnaires

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE SEVERITY SCORE; CONCURRENT VALIDITY; DISEASE EXACERBATION; DYSPNEA; EVALUATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; VALIDATION STUDY; VISUAL ANALOG SCALE;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 61649101317     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00087208     Document Type: Article

References (32)

1. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
2. Sobradillo V, Miravitlles M, Gabriel R, et al. Geographic variation in prevalence and underdiagnosis of COPD - results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-989.
3. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207.
4. Celli BR, Cote C, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
5. Derom E, van Weel C, Liistro G, et al. Primary care spirometry. Eur Respir J 2008; 31: 197-203.
6. Eisner MD, Trupin L, Katz PP, et al. Development and validation of a survey-based COPD severity score. Chest 2005; 127: 1890-1897.
7. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
8. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000; 94: 589-596.
9. Vilaró J, Gimeno E, Sánchez Férez N, et al. Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios. [Daily living activity in chronic obstructive pulmonary disease: validation of the Spanish version and comparative analysis of 2 questionnaires.] Med Clin (Barc) 2007; 129: 326-332.
10. Garrod R, Paul EA, Wedzicha JA. An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living scale (LCADL). Respir Med 2002; 96: 725-730.
11. Charlson ME, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251.
12. The EuroQol Group, EuroQol - a new facility for measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
13. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin (Barc) 1999; 112: Suppl. 1, 79-85.
14. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577.
15. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116: 1632-1637.
16. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 1997; 127: 1072-1079.
17. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
18. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004; 59: 387-395.
19. Llor C, Molina J, Naberan K, et al. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare. Int J Clin Pract 2008; 62: 585-592.
20. Rutten-van Mölken M, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006; 130: 1117-1128.
21. Warburton DER, Nicol CW, Bredin SSD. Health benefits of physical activity: the evidence. Can Med Assoc J 2006; 174: 801-809.
22. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-778.
23. Donaldson GC, Wilkinson TMA, Hurst JR, Perera WR, Wedzicha JA. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 446-452.
24. Soler-Cataluña JJ, Martinez-Gracía MA, Roman Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931.
25. Eisner MD, Katz P, Iribarren C, Yelin B, Blanc P. Measurement of COPD severity: further validation of a surveybased instrument. Eur Respir J 2007; 30: 629S.
26. Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Martín A. Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med 2007; 101: 1753-1760.
27. Schermer TR, Jacobs JE, Chavannes NH, et al. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax 2003; 58: 861-866.
28. Lusuardi M, De Benedetto F, Paggiaro P, et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice. Chest 2006; 129: 844-852.
29. Naberan K, de la Roza C, Lamban M, Gobartt E, Martín A, Miravitlles M. Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care. Arch Bronconeumol 2006; 42: 638-644.
30. Katz PP, Eisner MD, Yelin EH, et al. Functioning and psychological status among individuals with COPD. Qual Life Res 2005; 14: 1835-1843.
31. Müllerova H, Wedzicha J, Soriano JB, Vestbo J. Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med 2004; 98: 78-83.
32. Van der Molen T, Willemse BWM, Schokker S, ten Hacken NHT, Postma DS, Juniper EF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes 2003; 1: 13-22.